Pediatric pharmacokinetic considerations and implications for drug dosing
Optimizing the dosing of medicines for pediatric patients in routine clinical practice and determining the dose for clinical trials is still a challenging task. Children differ from adults in their response to drugs due to inherent differences in pharmacokinetics and/or pharmacodynamics, and respons...
Saved in:
Main Authors: | Jovanović Marija (Author), Vučićević Katarina (Author) |
---|---|
Format: | Book |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
by: Škorić Biljana, et al.
Published: (2020) -
Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
by: Roganović Maša, et al.
Published: (2021) -
Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine - Implications for dose considerations
by: Emma Eckernäs, et al.
Published: (2022) -
Pharmacokinetic Variability of Amikacin After Once-Daily and Twice-Daily Dosing Regimen in Full-Term Neonates
by: Katarina Vučićević, et al.
Published: (2014) -
Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling
by: Dhananjay D. Marathe, et al.
Published: (2023)